NewcelX NCEL
NASDAQ NCEL
$2.86 +0.11 (+4.00%)
At close: Nov 10, 2026 · 4:00 PM EST

NewcelX (NCEL) Other Non-Current Liabilities (2022 - 2025)

Updated

NewcelX (NCEL) recorded Other Non-Current Liabilities of $3.3 million in Q2 2025, up 159.3% from $1.27 million a year earlier.

Analysis

NewcelX (NCEL) Other Non-Current Liabilities (2022 - 2025) Analysis & Trends

At the end of FY2024, NewcelX reported Other Non-Current Liabilities of $1.27 million, unchanged from FY2023.

  • Across earlier years, Other Non-Current Liabilities came in at $1.27 million in FY2023 (-53.6%) and $2.75 million in FY2022.
  • On a year-over-year basis, Other Non-Current Liabilities rose in 1 of the last four quarters, with growth averaging 26.4%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 NewcelX 10.69 Mn 4.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 3.30 Mn
Dec 31, 2024 1.27 Mn
Jun 30, 2024 1.27 Mn
Dec 31, 2023 1.27 Mn
Jun 30, 2023 1.27 Mn
Dec 31, 2022 2.75 Mn
API Access

NewcelX Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NCEL&period=max&api_key=YOUR_API_KEY